Free Trial

Franklin Resources Inc. Invests $15.84 Million in Ardent Health Partners, LLC (NYSE:ARDT)

Ardent Health Partners logo with Medical background

Franklin Resources Inc. purchased a new stake in shares of Ardent Health Partners, LLC (NYSE:ARDT - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 839,351 shares of the company's stock, valued at approximately $15,839,000. Franklin Resources Inc. owned about 0.59% of Ardent Health Partners as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the business. Allspring Global Investments Holdings LLC bought a new position in shares of Ardent Health Partners during the 3rd quarter valued at approximately $13,119,000. Goldentree Asset Management LP bought a new position in shares of Ardent Health Partners in the third quarter worth approximately $22,897,000. Systematic Financial Management LP purchased a new stake in shares of Ardent Health Partners in the third quarter worth $595,000. Point72 Asset Management L.P. bought a new stake in shares of Ardent Health Partners during the 3rd quarter valued at $27,428,000. Finally, Wellington Management Group LLP purchased a new position in shares of Ardent Health Partners during the 3rd quarter valued at $28,724,000.

Analyst Ratings Changes

A number of brokerages have issued reports on ARDT. JPMorgan Chase & Co. reiterated a "neutral" rating and issued a $20.00 price target on shares of Ardent Health Partners in a research note on Tuesday. KeyCorp assumed coverage on Ardent Health Partners in a research note on Friday, October 11th. They set an "overweight" rating and a $24.00 target price on the stock. Stephens restated an "overweight" rating and issued a $24.00 price target on shares of Ardent Health Partners in a research note on Thursday, September 19th. Royal Bank of Canada reiterated an "outperform" rating and set a $23.00 price objective on shares of Ardent Health Partners in a research report on Thursday, November 14th. Finally, Leerink Partners upped their target price on shares of Ardent Health Partners from $23.00 to $25.00 and gave the stock an "outperform" rating in a research report on Tuesday, November 12th. Two investment analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus target price of $22.00.

Get Our Latest Report on Ardent Health Partners

Ardent Health Partners Trading Down 0.2 %

ARDT traded down $0.04 on Friday, hitting $16.01. The company had a trading volume of 487,247 shares, compared to its average volume of 345,148. Ardent Health Partners, LLC has a 12-month low of $14.57 and a 12-month high of $20.72. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78. The company's fifty day moving average is $17.24.

Ardent Health Partners Profile

(Free Report)

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.

Further Reading

Institutional Ownership by Quarter for Ardent Health Partners (NYSE:ARDT)

Should you invest $1,000 in Ardent Health Partners right now?

Before you consider Ardent Health Partners, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health Partners wasn't on the list.

While Ardent Health Partners currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines